Kaunas, Lithuania, 2011-09-20 15:13 CEST (GLOBE NEWSWIRE) --
On 20 September 2011 AB SANITAS received a report from its shareholder Valeant Pharmaceuticals International, Inc. on the implementation of the mandatory non-competitive tender offer.
Through the implementation period of the tender offer Valeant Pharmaceuticals International, Inc. bought-up 1,968,631 ordinary registered shares of AB SANITAS with nominal value of LTL 1 each (ISIN code LT0000106171), which represent 6.33 percent of voting rights at the general meeting of shareholders of the company.
Enclosed: The statement on the implementation of the tender offer.
This announcement is also available on AB SANITAS’ website: www.sanitasgroup.com.
A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of AB SANITAS, phone number +370 686 67779.
Lawyer
Dovilė Morkytė
+370 615 15163
